GO:0019563 glycerol catabolic process: Glycerol Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019563 glycerol catabolic process describes the biochemical reactions and pathways that break down glycerol (1,2,3-propanetriol), a sweet, hygroscopic, viscous liquid widely distributed in nature as a constituent of many lipids.
• The pathway is central to energy metabolism, gluconeogenesis, and lipid synthesis, and is conserved from bacteria to humans.
• Key enzymes include glycerol kinase (GK), glycerol-3-phosphate dehydrogenase (GPDH), and glycerol dehydrogenase, which channel glycerol into glycolysis or gluconeogenesis.
• Aquaporins (AQP3, AQP7, AQP9) facilitate glycerol transport across membranes, linking glycerol catabolism to systemic metabolic regulation.
• Dysregulation of glycerol catabolism contributes to nonalcoholic fatty liver disease, cancer, and metabolic disorders, making it a therapeutic target.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of glycerol catabolic genes in health and disease.
Description
Glycerol catabolic process (GO:0019563) is the set of chemical reactions and pathways that result in the breakdown of glycerol, a three-carbon sugar alcohol that is a constituent of many lipids and a key metabolite in energy homeostasis. This process is essential for converting glycerol into intermediates that feed glycolysis, gluconeogenesis, and lipid synthesis, thereby integrating carbohydrate and lipid metabolism. In humans, glycerol released from adipose tissue lipolysis is taken up by the liver and other tissues, where it is phosphorylated and oxidized to enter central metabolic pathways. The pathway is also critical in microorganisms, where it supports growth under osmotic stress and contributes to biotechnological production of value-added compounds. Understanding glycerol catabolism is therefore important for researchers studying metabolic diseases, cancer, and microbial physiology.
glycerol catabolic process At A Glance
| GO ID | GO:0019563 |
|---|---|
| GO term | glycerol catabolic process |
| Ontology | biological_process |
| Synonym | glycerol breakdown; glycerol catabolism; glycerol degradation |
| Definition | The chemical reactions and pathways resulting in the breakdown of glycerol, 1,2,3-propanetriol, a sweet, hygroscopic, viscous liquid, widely distributed in nature as a constituent of many lipids. |
| Major function | Conversion of glycerol into metabolic intermediates for energy production, gluconeogenesis, and lipid synthesis. |
| Key enzymes | Glycerol kinase (GK), glycerol-3-phosphate dehydrogenase (GPDH), glycerol dehydrogenase. |
| Transporters | Aquaporins (AQP3, AQP7, AQP9) facilitate glycerol movement across membranes. |
| Related pathways | Glycolysis, gluconeogenesis, lipogenesis, and redox balance. |
What Is GO:0019563?
The glycerol catabolic process (GO:0019563) encompasses the chemical reactions and pathways that result in the breakdown of glycerol, also known as 1,2,3-propanetriol, a sweet, hygroscopic, viscous liquid that is widely distributed in nature as a constituent of many lipids. This biological process includes the enzymatic conversion of glycerol into downstream metabolites such as glycerol-3-phosphate, dihydroxyacetone phosphate, and ultimately pyruvate or glucose, depending on the organism and physiological context.
Why Is glycerol catabolic process Important in Cell Biology?
Glycerol catabolic process is a metabolic hub that connects lipid breakdown to glucose production and energy supply, and its dysregulation is implicated in major human diseases including nonalcoholic fatty liver disease, cancer, and metabolic syndrome. In the liver, glycerol kinase drives de novo lipogenesis and triglyceride synthesis, contributing to steatosis. In cancer cells, glycerol metabolism supports rapid proliferation and survival under metabolic stress. Moreover, glycerol catabolism is exploited in biotechnology for the production of fuels and chemicals, and in hypersaline environments for osmoadaptation. Thus, understanding this pathway is essential for both fundamental biology and translational applications.
• Provides a link between lipolysis and hepatic gluconeogenesis, influencing blood glucose levels.
• Supports de novo lipogenesis and triglyceride synthesis in nonalcoholic fatty liver disease.
• Enables cancer cells to adapt to metabolic stress and sustain proliferation.
• Facilitates osmoadaptation in halophilic microorganisms.
• Underpins industrial bioproduction of glycerol-derived chemicals and fuels.
• Regulates systemic energy balance through AMPK-mediated glycerol excretion.
• Involves aquaporin-mediated glycerol transport, linking membrane physiology to metabolism.
• Serves as a model pathway for studying enzyme kinetics and metabolic engineering.
• Contributes to redox homeostasis via glycerol-3-phosphate shuttle.
• Offers therapeutic targets for metabolic disorders and cancer.
What Happens During glycerol catabolic process?
Glycerol uptake and transport
In simple terms: Glycerol must first enter the cell or organelle before it can be broken down.
Glycerol is a small polar molecule that requires aquaporins (AQP3, AQP7, AQP9) for efficient transport across cell membranes. In adipocytes, AQP7 facilitates glycerol efflux during lipolysis, while in liver and kidney, AQP9 mediates glycerol uptake. In microorganisms, glycerol uptake is often mediated by facilitated diffusion or active transport systems. This step is critical for determining the rate of glycerol catabolism in different tissues.
Phosphorylation by glycerol kinase
In simple terms: The first committed step traps glycerol inside the cell by adding a phosphate group.
Glycerol kinase (GK) catalyzes the ATP-dependent phosphorylation of glycerol to glycerol-3-phosphate (G3P). This reaction is the rate-limiting step of glycerol catabolism in many organisms and is highly regulated. In humans, GK is predominantly expressed in liver, kidney, and testes, and its activity is linked to hepatic lipogenesis. In bacteria and yeast, glycerol kinase is also essential for glycerol utilization.
Oxidation to dihydroxyacetone phosphate
In simple terms: Glycerol-3-phosphate is converted into a molecule that can enter glycolysis or gluconeogenesis.
Glycerol-3-phosphate is oxidized by glycerol-3-phosphate dehydrogenase (GPDH) to dihydroxyacetone phosphate (DHAP), generating reducing equivalents (NADH or FADH2). DHAP is an intermediate of glycolysis and gluconeogenesis, allowing glycerol carbon to be used for energy production or glucose synthesis. In some organisms, an alternative pathway via glycerol dehydrogenase converts glycerol directly to dihydroxyacetone, which is then phosphorylated.
Entry into central metabolism
In simple terms: The breakdown products feed into the main energy-producing pathways of the cell.
DHAP enters glycolysis to produce pyruvate and ATP, or is used for gluconeogenesis to synthesize glucose. In the liver, glycerol-derived DHAP can also be acylated to form triglycerides, contributing to lipid storage. The fate of glycerol carbon depends on the organism, tissue, and hormonal signals such as glucagon and insulin.
Regulation by energy status
In simple terms: The cell adjusts glycerol breakdown based on its energy needs.
AMPK regulates glycerol excretion and maintains metabolic crosstalk between reductive and energetic stress, thereby influencing glycerol catabolism. Glucagon shifts substrate preference in gluconeogenesis, promoting glycerol utilization for glucose production. In cancer cells, oncogenic signaling can upregulate glycerol catabolic enzymes to support growth.
Key Genes Involved in GO:0019563 glycerol catabolic process
The following genes and proteins are central to glycerol catabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GK | Phosphorylates glycerol to glycerol-3-phosphate | Rate-limiting enzyme; linked to hepatic steatosis and lipogenesis |
| GPD1 | Cytosolic glycerol-3-phosphate dehydrogenase | Redox balance and glycerol catabolism in yeast and human |
| GPD2 | Mitochondrial glycerol-3-phosphate dehydrogenase | Glycerol-3-phosphate shuttle; energy metabolism |
| AQP3 | Aquaporin glycerol transporter | Glycerol transport in skin and kidney |
| AQP7 | Aquaporin glycerol transporter | Adipocyte glycerol efflux; linked to obesity |
| AQP9 | Aquaporin glycerol transporter | Hepatic glycerol uptake; metabolic regulation |
| GCK | Glucokinase | Indirectly linked to glycerol metabolism via glycolysis |
| ALDOB | Aldolase B | Metabolizes DHAP in glycolysis/gluconeogenesis |
| TPI1 | Triosephosphate isomerase | Interconverts DHAP and G3P |
| PDK1 | Pyruvate dehydrogenase kinase | Regulates entry of glycerol carbon into TCA cycle |
| SREBP-1c | Transcription factor for lipogenesis | Upregulated by glycerol kinase; promotes DGAT1/2 |
| DGAT1 | Diacylglycerol O-acyltransferase 1 | Triglyceride synthesis from glycerol-derived DHAP |
| DGAT2 | Diacylglycerol O-acyltransferase 2 | Triglyceride synthesis; target in NAFLD |
| AMPK | Energy sensor kinase | Regulates glycerol excretion and catabolism |
| PPARα | Nuclear receptor | Promotes fatty acid oxidation and glycerol utilization |
| FBP1 | Fructose-1,6-bisphosphatase | Gluconeogenesis from glycerol |
| PCK1 | Phosphoenolpyruvate carboxykinase | Gluconeogenesis; glycerol conversion to glucose |
How Is glycerol catabolic process Regulated?
Glycerol catabolic process is regulated at multiple levels. In mammals, hormonal signals such as glucagon and insulin control the flux of glycerol into gluconeogenesis or lipogenesis. AMPK senses energy stress and regulates glycerol excretion, thereby maintaining metabolic crosstalk between reductive and energetic stress. In the liver, glycerol kinase expression and activity are modulated by SREBP-1c, which upregulates DGAT1/2 and promotes triglyceride synthesis. In microorganisms, glycerol catabolism is regulated by osmotic stress and carbon source availability. Additionally, aquaporin expression is dynamically regulated in metabolic organs, affecting glycerol transport and subsequent catabolism.
glycerol catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GK | Nonalcoholic fatty liver disease | Liver-specific knockout or overexpression in mice |
| AQP7 | Obesity and insulin resistance | Adipocyte-specific knockout |
| AQP9 | Metabolic syndrome | Hepatic knockout or knock-in |
| GPD2 | Cancer metabolism | Cancer cell line knockout |
| AMPK | Energy stress and metabolic disorders | Knockout or point mutation in metabolic tissues |
Nonalcoholic fatty liver disease (NAFLD)
Glycerol kinase drives hepatic de novo lipogenesis and triglyceride synthesis by activating SREBP-1c and upregulating DGAT1/2, contributing to NAFLD pathogenesis. Elevated glycerol catabolism in the liver promotes steatosis and insulin resistance.
Cancer metabolism
Glycerol and glycerol-3-phosphate are multifaceted metabolites in cancer, supporting rapid proliferation and survival under metabolic stress. Glycerol catabolic enzymes are often upregulated in tumors to sustain lipid synthesis and energy production.
Metabolic syndrome and obesity
Aquaporin-mediated glycerol transport in adipocytes and liver is linked to obesity and metabolic syndrome. Dysregulated glycerol catabolism affects systemic glucose and lipid homeostasis.
From glycerol catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GK causally drive hepatic lipogenesis? | Liver-specific GK knockout mouse |
| How does AQP7 affect glycerol efflux and obesity? | Adipocyte-specific AQP7 knockout mouse |
| What is the role of AMPK in glycerol excretion? | AMPK knockout or point-mutation cell lines |
| Can glycerol catabolism be targeted in cancer? | Cancer cell lines with GPD2 knockout or overexpression |
| How does glucagon regulate glycerol gluconeogenesis? | Primary hepatocytes with glucagon treatment and CRISPR knockouts |
| What is the impact of glycerol kinase mutations on enzyme activity? | Knock-in of patient-derived mutations in cell lines |
How to Study the glycerol catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C-glycerol tracing | Metabolic flux through glycerol catabolism | Liver and cancer cell metabolism |
| CRISPR knockout screening | Genes required for glycerol utilization | Identify novel regulators |
| RNA-seq | Transcriptional changes in pathway genes | Response to fasting or hormonal signals |
| Proteomics | Protein abundance of enzymes | Tissue-specific expression profiling |
| Enzyme activity assay | Catalytic activity of GK or GPDH | Functional validation of mutations |
| Aquaporin transport assay | Glycerol permeability | Adipocyte and hepatocyte studies |
| Seahorse extracellular flux | Real-time glycolysis and oxidation | Metabolic phenotyping of knockout cells |
| Lipidomics | Triglyceride and phospholipid species | NAFLD and cancer models |
Metabolic flux analysis
Isotope tracing with 13C-glycerol coupled to mass spectrometry quantifies the flux of glycerol carbon into glycolysis, gluconeogenesis, and lipid synthesis. This method is essential for understanding pathway dynamics in health and disease.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes required for glycerol catabolism and its crosstalk with other metabolic pathways. Such screens have revealed roles for glycerol kinase and aquaporins in metabolic regulation.
Transcriptomics and proteomics
RNA-seq and proteomics reveal expression changes in glycerol catabolic enzymes under different physiological conditions, such as fasting or high-fat diet. These approaches help identify regulatory networks involving SREBP-1c and AMPK.
Enzyme activity assays
Direct measurement of glycerol kinase and glycerol-3-phosphate dehydrogenase activities in tissue lysates or purified preparations provides biochemical validation of pathway function. These assays are often combined with genetic perturbations.
How CRISPR Can Be Used to Study GO:0019563 glycerol catabolic process
Knockout
CRISPR knockout of glycerol kinase (GK) or aquaporins (AQP7, AQP9) in cell lines and animal models abolishes or reduces glycerol catabolism, enabling causal studies of its role in lipogenesis, gluconeogenesis, and cancer. Liver-specific GK knockout mice show reduced hepatic steatosis.
Point Mutation
Point mutations in GK or GPDH can mimic human genetic variants, allowing assessment of their impact on enzyme activity and metabolic flux. Such models are valuable for understanding disease-associated mutations in glycerol catabolism.
Knock-in
Knock-in of tagged versions of glycerol catabolic enzymes (e.g., GFP-GK) enables live-cell imaging and interaction studies. Knock-in of patient-derived mutations provides personalized models for metabolic disorders.
Overexpression
Overexpression of glycerol kinase or glycerol-3-phosphate dehydrogenase in cell lines or mice increases glycerol catabolic flux, promoting lipogenesis and triglyceride accumulation. This approach is used to model NAFLD and cancer metabolic reprogramming.
How EDITGENE Supports glycerol catabolic process Research
Researchers studying glycerol catabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, metabolic disease, or cancer. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for glycerol catabolic process research.
Frequently Asked Questions About glycerol catabolic process
What is glycerol catabolic process?
Glycerol catabolic process (GO:0019563) is the set of biochemical reactions that break down glycerol into intermediates for energy production, gluconeogenesis, and lipid synthesis.
What genes are involved in glycerol catabolic process?
Key genes include GK, GPD1, GPD2, AQP3, AQP7, AQP9, and AMPK, among others.
How is glycerol catabolism regulated?
It is regulated by hormones such as glucagon and insulin, by AMPK in response to energy stress, and by transcription factors like SREBP-1c.
What is the role of glycerol kinase in glycerol catabolism?
Glycerol kinase catalyzes the rate-limiting phosphorylation of glycerol to glycerol-3-phosphate, which is essential for further breakdown.
How does glycerol catabolism contribute to fatty liver disease?
Glycerol kinase drives de novo lipogenesis and triglyceride synthesis by activating SREBP-1c and upregulating DGAT1/2, promoting steatosis.
Which aquaporins transport glycerol?
AQP3, AQP7, and AQP9 facilitate glycerol transport across cell membranes in various tissues.
Can CRISPR be used to study glycerol catabolism?
Yes, CRISPR knockout, knock-in, and overexpression models enable causal studies of glycerol catabolic genes in metabolic diseases and cancer.
What diseases are linked to glycerol catabolic process?
Nonalcoholic fatty liver disease, cancer, obesity, and metabolic syndrome are linked to dysregulated glycerol catabolism.
How is glycerol catabolism measured in the lab?
Methods include 13C-glycerol tracing, enzyme activity assays, RNA-seq, proteomics, and CRISPR screens.
What is the difference between glycerol catabolism and lipolysis?
Lipolysis is the breakdown of triglycerides into glycerol and fatty acids, while glycerol catabolism is the subsequent breakdown of glycerol itself.
Conclusion
Glycerol catabolic process (GO:0019563) is a fundamental metabolic pathway that connects lipid breakdown to energy production, gluconeogenesis, and lipogenesis. Its dysregulation is implicated in major diseases such as nonalcoholic fatty liver disease, cancer, and metabolic syndrome. Advances in CRISPR-based models and metabolic flux analysis continue to unravel the complex regulation of this pathway, offering new therapeutic opportunities. EDITGENE provides the tools and expertise to accelerate research on glycerol catabolism and its role in health and disease.
References
- 1. Ouyang S et al.. 2024. Glycerol Kinase Drives Hepatic de novo Lipogenesis and Triglyceride Synthesis in Nonalcoholic Fatty Liver by Activating SREBP-1c Transcription, Upregulating DGAT1/2 Expression, and Promoting Glycerol Metabolism.. Adv Sci (Weinh) 11(46):e2401311 PMID: 39418169
- 2. Oren A. 2017. Glycerol metabolism in hypersaline environments.. Environ Microbiol 19(3):851-863 PMID: 27511298
- 3. Zhai X et al.. 2025. AMPK-regulated glycerol excretion maintains metabolic crosstalk between reductive and energetic stress.. Nat Cell Biol 27(1):141-153 PMID: 39747579
- 4. Hibuse T et al.. 2006. Aquaporins and glycerol metabolism.. Biochim Biophys Acta 1758(8):1004-11 PMID: 16487477
- 5. Xu H et al.. 2022. Glucagon changes substrate preference in gluconeogenesis.. J Biol Chem 298(12):102708 PMID: 36402444
- 6. Madiraju SRM et al.. 2026. Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases.. Endocr Rev 47(1):93-120 PMID: 40927981
- 7. Semkiv MV et al.. 2020. 100 Years Later, What Is New in Glycerol Bioproduction?. Trends Biotechnol 38(8):907-916 PMID: 32584768
- 8. Tardelli M et al.. 2020. Aquaporin regulation in metabolic organs.. Vitam Horm 112:71-93 PMID: 32061350
